STERIS’ (TSE:STE – Free Report) – Research analysts at Atb Cap Markets lifted their Q1 2025 earnings per share estimates for STERIS’ in a report issued on Wednesday, March 12th. Atb Cap Markets analyst W. Syed now expects that the company will earn $0.35 per share for the quarter, up from their prior forecast of $0.29. Atb Cap Markets has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q3 2025 earnings at $0.27 EPS, Q1 2026 earnings at $0.40 EPS, Q2 2026 earnings at $0.12 EPS, Q3 2026 earnings at $0.32 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $0.89 EPS.
Separately, Cormark upgraded STERIS’ to a “moderate buy” rating in a research report on Monday, January 6th.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- What does consumer price index measure?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Stock Sentiment Analysis: How it Works
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Top Stocks Investing in 5G Technology
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
